Sigilon Therapeutics, Inc. (SGTX) has a market capitalization of $56.22M and trades at $22.47. The 52-week range is 3.77-28.0.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -16.8, Earnings Per Share (EPS) of $-1.34, annual revenue of $12.94M.
The stock has a beta of 4.11, operates in the Healthcare sector.
